Geriatric assessment as a predictor of postoperative complications in elderly patients with hepatocellular carcinoma

• DOI: 10.1007/s00423-016-1388-1
• Publication Date: 2016-02-23T19:07:39Z
• Authors: Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; Hiroya Iida; Kentaro Inoue; Fumio Nagashima; Masanori Kon
• Keywords: Aged, 80 and over; Male; Carcinoma, Hepatocellular; Liver Neoplasms; Age Factors; Nutritional Status; Sensitivity and Specificity; 3. Good health; Cohort Studies; 03 medical and health sciences; Postoperative Complications; 0302 clinical medicine; Risk Factors; Hepatectomy; Humans; Female; Geriatric Assessment; Aged

Older patients are considered to have increased risk for complications after major surgery, but age alone is not a reliable predictor of postoperative complications. However, no universal screening test adequately predicts postoperative complications in older patients. This prospective study recorded pertinent baseline geriatric assessment variables to identify risk factors for postoperative complications in hepatocellular carcinoma (HCC) for patients aged ≥70 years who undergo hepatectomy.We retrospectively analyzed 71 consecutive patients ≥70 years of age. Patients had geriatric assessments of baseline and later cognition, nutritional and functional status, and burden of comorbidities, completed preoperatively and at 1, 3, and 6 months postoperatively. Postoperative morbidities were recorded.Postoperative morbidities developed in 18 patients (25 %). Univariate analysis identified serum albumin, operating time and blood loss, cirrhosis, geriatric 8 (G8), and Mini Nutritional Assessment as possible risk factors for postoperative complications, but only G8 < 14 survived multivariate analysis as an independent predictor of complications.Our findings indicate that the G8 score, based on patients' nutritional assessments, is a useful screening method for older HCC patients who qualify for elective liver resection. Preoperative G8 scores can help forecast postoperative complications in older HCC patients. Future studies with larger numbers of patients, limited to HCC and liver resections, are needed to verify our results.